Professor Gerard Byrne
Professor

Gerard Byrne

Email: 
Phone: 
+61 7 336 55152

Background

Gerard Byrne is the Mayne Professor and Head of the Academy of Psychiatry within the Faculty of Medicine at the University of Queensland and Director of the Older Persons' Mental Health Service at the Royal Brisbane and Women's Hospital. His primary research interests include Alzheimer's disease (particularly the neuropsychiatric symptoms associated with AD), and personality, anxiety and depression in older people. Recent published work has included papers on generalised anxiety disorder in older people, dementia and delirium in the general hospital setting, and the role of lifestyle factors in predicting cognitive trajectory in middle age and later life.

Biography:

Gerard completed his medical degree and an intercalated science degree in Sydney at the University of New South Wales and the Prince of Wales and Prince Henry Hospitals. Following an internship at the Royal Newcastle Hospital, he undertook two further years of general medical training at The Prince Charles Hospital in Brisbane. He subsequently completed his five years of psychiatry training at The Prince Charles and Wolston Park Hospitals. His PhD in psychiatric epidemiology was undertaken at the University of Queensland under the supervision of Beverley Raphael AM. He has been Head of the UQ Discipline (now Academy) of Psychiatry since 2001 and Director of Geriatric Psychiatry (now the Older Persons' Mental Health Service) at the Royal Brisbane & Women’s Hospital since 1995.

He a member of the Repatriation Medical Authority and chairs the Research Advisory Committee of the Royal Brisbane & Women's Hospital. He is a member of the advisory board of the Clem Jones Centre for Ageing Dementia Research at the Queensland Brain Institute. He is a former member of the board of directors of the International Psychogeriatric Association.

He is a past chairman of the Faculty of Psychiatry of Old Age (FPOA) of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) and a former member of the RANZCP General Council. He is a former chair of the RANZCP Sub-committee for Advanced Training in Psychiatry of Old Age and member of the RANZCP Committee for Training. He is a member of the RANZCP Foundation Committee and a member of the Queensland Brain Bank Scientific Advisory Committee.

Gerard also serves as a member of NHMRC GRPs and reviews research grant applications for NHMRC, ARC, Hong Kong MRC, New Zealand RC, Netherlands Organisation for Health Research & Development (ZonMw), U.S. Alzheimer's Association, Alzheimer's Australia Research Fund, and Pfizer Neuroscience Research Grants, amongst others.

He is a member of the editorial board of the journal, Clinical Gerontologist.

He reviews manuscripts for Molecular Psychiatry, British Journal of Psychiatry, Biological Psychiatry, Brain and Cognition, Journal of Affective Disorders, Journal of the American Geriatrics Association (JAGS), Journal of Psychiatric Research, Journal of Alzheimer's Disease, Age and Ageing, Aging and Mental Health, American Journal of Geriatric Psychiatry, Australasian Journal on Ageing, Australian and New Zealand Journal of Psychiatry, Australian and New Zealand Journal of Public Health, BMC Psychiatry, Depression and Anxiety, International Journal of Geriatric Psychiatry and International Psychogeriatrics, amongst others.

In 2012 he won the Senior Research Award of the Royal Australian and New Zealand College of Psychiatrists.

In 2013 he delivered the Bostock Oration of the Royal Australian and New Zealand College of Psychiatrists.

In 2016 he was awarded a Meritorious Service Award by the Royal Australian and New Zealand College of Psychiatrists.

Availability

Professor Gerard Byrne is:
Not available for supervision
Media expert

Fields of research

Clinical sciences Health Sciences

Qualifications

  • Royal Australian and New Zealand College of Psychiatrists, Royal Australian and New Zealand College of Psychiatrists

Research interests

  • Synaptic Dysfunction in Alzheimer's Disease

    This project has been funded by the Alzheimer's Association (U.S.) and is being conducted in collaboration with Dr Rudi Tannenberg and A/Prof Peter Dodd in Dr Dodd's laboratory in the School of Microbial and Molecular Sciences.

  • Anxiety & Depression During Cognitive Ageing

    This 3-year NHMRC-funded study will look at the emergence of syndromal and sub-syndromal anxiety and depression in a cohort of 511 women from the LAW Study being conducted at the Royal Brisbane & Women's Hospital. For further information on this study contact Liz Arnold on 07 3365 5147.

  • Neuropsychiatric Symptoms in Alzheimer's Disease

    Data collection has commenced on a prospective study of predictors of incident neuropsychiatric symptoms in patients with late-onset Alzheimer disease. This research project will run for about five or six years - two to three years to recruit the participants and 30 months to complete the longitudinal data collection on each participant. This work is being funded by a generous bequest via the RBWH Research Foundation. For further information on this project, please contact <b> Liz Arnold </b>on (07) 3365 5147.

  • International collaborations using interRAI

    We are engaged in clinical validation of the interRAI instrument for cross-national data collection in older person's mental health services. For further information please contact Gerard Byrne on 07 3365 5148.

  • Clinical Drug Trials for Alzheimer's disease

    We are currently involved in several clinical pharmaceutical trials of new drugs or new formulations of existing drugs for the treatment of mild to moderate Alzheimer's disease. For further information on these projects, please contact <b>Liz Arnold</b> on 3365 5147.

  • Measurement of Anxiety in Older People

    This program of collaborative research with Dr Nancy Pachana (School of Psychology) has been underway for about 12 months. The aim of this program is to develop a novel measure of generalised anxiety for use in older people. No such measure currently exists. We plan to use factor analysis and discriminant function analysis to shrink the current draft 60 item scale to 20 or 30 items for everyday use. We will then publish the scale in the public domain. Subsequently, we will use the scale to investigate genetic and other predictors of generalised anxiety in older people. Ultimately, we hope to be able to use the scale as an outcome measure for treatment trials in older people. We anticipate that this research program will continue for 5-10 years.

  • Development of Cogni-Screen: A Diagnostic System for Dementia

    In a collaborative project with Prof Mike Humphreys (Key Centre for Human Factors & Applied Cognitive Psychology), Dr Nancy Pachana (School of Psychology) & Prof Chris Del Mar (Griffith University) we are developing a computerised diagnostic system for dementia. This system involves a web-based real-time system using speech recognition software. The project has been funded by grants from the NHMRC and the Telstra Broadband Development Fund.

  • Depression in Stroke Patients

    Data collection for this three-year project on the value of clinical guidelines for the diagnosis and management of major depression in stroke patients is almost completed. This Queensland Health funded project involved the development and implementation of clinical guidelines within the RBWH Stroke Service. To measure the clinical utility of these guidelines, two cohorts of 100 stroke patients have been enrolled: one prior to the development of the guidelines and one following their introduction.

  • Personality and Depression following Stroke

Research impacts

Prof Gerard Byrne and Prof Nancy Pachana have been engaged in a longterm program of research into anxiety in later life. With the assistance of students and colleagues, they have developed a suite of instruments to measure anxiety in older people. These instruments include the Geriatric Anxiety Inventory (GAI), the Geriatric Anxiety Inventory - Short Form (GAI-SF), the Geriatric Anxiety Inventory - Research (GAI-R), and the Informant Questionnaire for Anxiety in Dementia (IQAD). The GAI has now been translated into more than 20 languages and is in widespread use throughout the world. It is used in both clinical and research settings. It has also been used by the pharmaceutical industry in international multisite clinical trials. The availability of the GAI and associated measures has increased focus on the anxiety disorders in older people, which had previously been relatively neglected by clinicians and researchers alike.

Search Professor Gerard Byrne’s works on UQ eSpace

378 works between 1982 and 2025
All (378) Journal Article (196) Book Chapter (9) Conference Publication (167) Book (4) Other Outputs (2)

341 - 360 of 378 works

2005

Journal Article

Pharmacological treatment of behavioural problems in dementia

Byrne, G. J. (2005). Pharmacological treatment of behavioural problems in dementia. Australian Prescriber, 28 (3), 67-70. doi: 10.18773/austprescr.2005.052

Pharmacological treatment of behavioural problems in dementia

2005

Conference Publication

Screening for anxiety in mild cognitvely impaired individuals

Boddice, G., Pachana, N. A. and Byrne, G. J. A. (2005). Screening for anxiety in mild cognitvely impaired individuals. Informing Psychological Interventions: The 1st APS Psychology and Ageing Interest Group Conference, Deakin Management Centre, Geelong, Victoria, 4-5 November, 2005. Basingstoke, U.K.: Taylor and Francis. doi: 10.1080/00049530600940011

Screening for anxiety in mild cognitvely impaired individuals

2005

Journal Article

Reduced extrapyramidal symptoms and tardive dyskinesia in patients with dementia receiving low-dose risperidone compared to low-dose haloperidol: A systematic review

Woodward, Michael, Ames, David, Aldridge, Graily, Brodaty, Henry, Byrne, Gerard, Snowden, John and Hertel, Judy (2005). Reduced extrapyramidal symptoms and tardive dyskinesia in patients with dementia receiving low-dose risperidone compared to low-dose haloperidol: A systematic review. International Psychogeriatrics, 17 (S2), 173-174. doi: 10.1017/S104161020500236X

Reduced extrapyramidal symptoms and tardive dyskinesia in patients with dementia receiving low-dose risperidone compared to low-dose haloperidol: A systematic review

2005

Conference Publication

A systematic review of extrapyramidal symptoms and tardive dyskinesia in patients with dementia receiving low-dose risperidone vs low-dose haloperidol

Brodaty, H., Aldridge, G., Ames, D., Byrne, G. J. A., Snowdon, J., Woodward, M. and Hertel, J. (2005). A systematic review of extrapyramidal symptoms and tardive dyskinesia in patients with dementia receiving low-dose risperidone vs low-dose haloperidol. The Royal Australian & NZ College of Psychiatrists 40th Congress, Sydney, NSW, 22-26 May, 2005. Melbourne, Australia: Blackwell. doi: 10.1111/j.1440-1614.2005.01674.x

A systematic review of extrapyramidal symptoms and tardive dyskinesia in patients with dementia receiving low-dose risperidone vs low-dose haloperidol

2005

Conference Publication

Measurement of anxiety symptoms in older adults: The Geriatric Anxiety Inventory

Pachana, N. A. and Byrne, G. J. A. (2005). Measurement of anxiety symptoms in older adults: The Geriatric Anxiety Inventory. 1st APS Psychology and Ageing Interest Group Conference, Geelong, Victoria, 4-5 November 2005. Basingstoke, England: Taylor and Francis. doi: 10.1080/00049530600940011

Measurement of anxiety symptoms in older adults: The Geriatric Anxiety Inventory

2005

Journal Article

Child maltreatment, child protection and mental health

Paz, Isabel, Jones, David and Byrne, Gerry (2005). Child maltreatment, child protection and mental health. Current Opinion in Psychiatry, 18 (4), 411-421. doi: 10.1097/01.yco.0000172061.93896.26

Child maltreatment, child protection and mental health

2005

Journal Article

Reduced Extrapyramidal Symptoms and Tardive Dyskinesia in patients with dementia receiving low-dose risperidone compared to low-dose haloperidol: A systematic review

Boundy, K., Woodward, M., Ames, D., Aldridge, G., Brodaty, H., Byrne, G., Snowdon, J. and Hertel, J. (2005). Reduced Extrapyramidal Symptoms and Tardive Dyskinesia in patients with dementia receiving low-dose risperidone compared to low-dose haloperidol: A systematic review. Journal of The Neurological Sciences, 238, S304-S304.

Reduced Extrapyramidal Symptoms and Tardive Dyskinesia in patients with dementia receiving low-dose risperidone compared to low-dose haloperidol: A systematic review

2004

Journal Article

Outcomes for elderly patients with mental illness following relocation from a stand-alone psychiatric hospital to community-based extended care units

Meehan, Tom, Robertson, Samantha, Stedman, Terry and Byrne, Gerard (2004). Outcomes for elderly patients with mental illness following relocation from a stand-alone psychiatric hospital to community-based extended care units. Australian and New Zealand Journal of Psychiatry, 38 (11-12), 948-952. doi: 10.1080/j.1440-1614.2004.01490.x

Outcomes for elderly patients with mental illness following relocation from a stand-alone psychiatric hospital to community-based extended care units

2004

Journal Article

The influence of postmenopausal hormone replacement therapy on cognitive functioning: Results from an observational study

King, R., Travers, C., O'Neill, S., Byrne, G. and Khoo, S. K. (2004). The influence of postmenopausal hormone replacement therapy on cognitive functioning: Results from an observational study. Journal of the British Menopause Society, 10 (3), 103-107. doi: 10.1258/1362180043654584

The influence of postmenopausal hormone replacement therapy on cognitive functioning: Results from an observational study

2004

Journal Article

Seclusion use with children and adolescents: an Australian experience

Fryer, M. A., Beech, M. and Byrne, G. J. A. (2004). Seclusion use with children and adolescents: an Australian experience. Australian and New Zealand Journal of Psychiatry, 38 (1/2), 26-33. doi: 10.1111/j.1440-1614.2004.01294.x

Seclusion use with children and adolescents: an Australian experience

2004

Journal Article

WHOQOL-BREF as a measure of quality of life in older patients with depression

Naumann, V. J. and Byrne, G. J. A. (2004). WHOQOL-BREF as a measure of quality of life in older patients with depression. International Psychogeriatrics, 16 (2), 159-173. doi: 10.1017/S1041610204000109

WHOQOL-BREF as a measure of quality of life in older patients with depression

2004

Book Chapter

Depression in older people

Byrne, G. J. A. (2004). Depression in older people. Mood Disorders: Recognition & Treatment. (pp. 410-420) edited by P. R. Joyce and P. B. Mitchell. Sydney, Australia: University of New South Wales.

Depression in older people

2003

Journal Article

Substance-use disorders and psychological distress among police arrestees

Heffernan, Edward B., Finn, Joe, Saunders, John B. and Byrne, Gerard (2003). Substance-use disorders and psychological distress among police arrestees. Medical Journal of Australia, 179 (8), 408-411.

Substance-use disorders and psychological distress among police arrestees

2002

Journal Article

Behaviour of older people admitted for residential respite care

Neville, Christine C. and Byrne, Gerard J.A. (2002). Behaviour of older people admitted for residential respite care. Australian Journal of Advanced Nursing, 20 (1), 8-12.

Behaviour of older people admitted for residential respite care

2002

Journal Article

Behaviour of Older People Admitted for Residential Respite Care

Neville, Christine C. and Byrne, Gerard J. A. (2002). Behaviour of Older People Admitted for Residential Respite Care. Australian Journal of Advanced Nursing, 20 (1), 8-12.

Behaviour of Older People Admitted for Residential Respite Care

2002

Journal Article

Does premorbid personality predict behavioural and psychological symptoms of dementia?

Slack, C and Byrne, G (2002). Does premorbid personality predict behavioural and psychological symptoms of dementia?. Australian And New Zealand Journal of Psychiatry, 36 (6), A4-A5.

Does premorbid personality predict behavioural and psychological symptoms of dementia?

2002

Journal Article

What happens to anxiety disorders in later life?

Byrne, Gerard J. A. (2002). What happens to anxiety disorders in later life?. Revista Brasileira de Psiquiatria, 24 (Suppl 1), 41-47. doi: 10.1590/S1516-44462002000500014

What happens to anxiety disorders in later life?

2001

Journal Article

Behaviour rating scales for older people with dementia: Which is the best for use by nurses?

Neville, Christine C. and Byrne, Gerard J. A. (2001). Behaviour rating scales for older people with dementia: Which is the best for use by nurses?. Australasian Journal On Ageing, 20 (4), 166-172. doi: 10.1111/j.1741-6612.2001.tb00381.x

Behaviour rating scales for older people with dementia: Which is the best for use by nurses?

2001

Journal Article

Behaviour rating scales for older people with dementia: which is the best for use by nurses?

Neville, Christine C. and Byrne, Gerard J. A. (2001). Behaviour rating scales for older people with dementia: which is the best for use by nurses?. Australasian Journal of Ageing, 20 (4), 166-172.

Behaviour rating scales for older people with dementia: which is the best for use by nurses?

2001

Journal Article

The Hopkins verbal learning test had high sensitivity and good specificity for detecting mild dementia in older adults

Frank, R. M. and Byrne, G. J. (2001). The Hopkins verbal learning test had high sensitivity and good specificity for detecting mild dementia in older adults. Evidence-Based Medicine, 6 (2), 57-57. doi: 10.1136/ebm.6.2.57

The Hopkins verbal learning test had high sensitivity and good specificity for detecting mild dementia in older adults

Current funding

  • 2024 - 2027
    Cognitive Biomarkers of Response to TMS for Depression (QHCRF externally led by GCHHS)
    Gold Coast Hospital and Health Services
    Open grant
  • 2024 - 2026
    A bedside cognitive tool to individualise care for an innovative evidence-based treatment for depression (QHCRF administered by Gold Coast HHS)
    Gold Coast Hospital and Health Services
    Open grant
  • 2023 - 2027
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2021 - 2026
    Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT)
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2021 - 2025
    Which older people with psychotic disorders are most likely to experience anxiety and how should this be managed?
    Royal Australian & New Zealand College Psychiatrists
    Open grant

Past funding

  • 2021 - 2022
    Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease
    Metro North Hospital and Health Service
    Open grant
  • 2021 - 2022
    Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease (TRIP study)
    Metro North Hospital and Health Service
    Open grant
  • 2018 - 2019
    Virtual reality innovation to treat anxiety in patients with cognitive impairment and Parkinson's Disease
    Metro North Hospital and Health Service
    Open grant
  • 2016 - 2019
    Protocol 17X-MC-LLCF: Effect of LY3202626 on Alzheimer's disease progression as measured by cerebral 18F-AV-1451 Tau-PET in mild Alzheimer's disease dementia
    Eli Lilly Australia Pty Ltd
    Open grant
  • 2016 - 2022
    A Phase 2b/3 randomized, double-blind, placebo-controlled, parallel group, multicentre study investigating the efficacy and safety of JNJ54861911 in subjects who are asymptomatic at risk for develo...
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2016
    Protocol RVT-101-3001: A phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer's disease
    Worldwide Clinical Trials Pty Limited
    Open grant
  • 2016 - 2017
    Cognitive behaviour therapy for anxiety in Parkinson's disease: outcomes for patients and caregivers
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2016 - 2020
    N-Acetyl Cysteine in the Adjunctive Treatment of Obsessive Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study (NHMRC Project Grant admin. by Western Sydney University)
    Western Sydney University
    Open grant
  • 2015 - 2019
    A phase 3 multicentre, randomised, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of aducanumab (BIIB037) in subjects with early Alzheimer's Disease
    Biogen Australia
    Open grant
  • 2015 - 2023
    Prospective Imaging Study of Ageing: Genes, Brain & Behaviour (NHMRC Dementia Research Team Grant administered by QIMR Berghofer Medical Research Institute)
    Queensland Institute of Medical Research
    Open grant
  • 2015 - 2018
    Protocol No. TRx-237-020: An open-label, extension study of the effects of leuco-methylthioninium bis(hydromethanesulfonate) in subjects with Alzheimer's disease or behavioral variant frontotempora...
    Worldwide Clinical Trials Pty Limited
    Open grant
  • 2015 - 2016
    Mindfulness therapy for depression, anxiety, motor and cognitive dysfunction in Parkinson's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2015
    Transcranial direct current stimulation to improve cognition and learning in prodromal Alzheimer's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2018
    Clinical Study No. 14863A, Randomised, double-blind. parallel-group, placebo-controlled study of LuAE58054 in patients with mild-moderate Alzheimer's disease ...
    Lundbeck Australia Pty Ltd
    Open grant
  • 2014 - 2017
    Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Trial of Leuco methylthioninium bis(hydromethanesulfonate) in Subjects with Mild to Moderate Alzheimer's Disease
    Worldwide Clinical Trials Pty Limited
    Open grant
  • 2014 - 2016
    Developing a non-invasive composite measure to enhance accuracy of identifying anxiety in Parkinson's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2017
    Kava for the Treatment of Generalized Anxiety Disorder: A 16-Week Double-Blind RCT (NHMRC Project Grant administered by the University of Melbourne)
    University of Melbourne
    Open grant
  • 2013 - 2015
    Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) versus Placebo
    Eli Lilly Australia Pty Ltd
    Open grant
  • 2013 - 2017
    Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of Leuco methylthioninium bis(hydromethanesulfonate) in Subjects with Mild to Moderate Alzheimer's Disease
    Worldwide Clinical Trials Pty Limited
    Open grant
  • 2013 - 2014
    Characterising anxiety in Parkinson's disease: A psycholinguistic and psychophysiology study comparing to anxious older adults
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2013 - 2017
    The Efficacy of Adjunctive S-Adenosyl Methionine (SAMe) versus a Combination Nutraceutical in Clinical Depression. (NHMRC Project grant administered by University of Melbourne)
    University of Melbourne
    Open grant
  • 2012 - 2013
    Improving diagnostic methods of anxiety disorders in Parkinson's disease: Phase 2
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2012 - 2015
    Psychosis Research
    Research Donation Generic
    Open grant
  • 2011 - 2013
    Measures of cholinergic basal forebrain degeneration as an early screen for Alzheimer's disease
    The Mason Foundation - Medical and Scientific Research Grants
    Open grant
  • 2011 - 2013
    The Pathophysiology of Excitotoxicity in Alzheimer's Disease
    The Mason Foundation - Medical and Scientific Research Grants
    Open grant
  • 2011 - 2013
    Clinical Study No. DRI10734, [......] tolerability of SAR110894D at the doses of 0.5 mg, 2 mg, and 5 mg/day for 24 weeks in patients with mild to moderate Alzheimer's Disease on stable donepezil
    Sanofi-Aventis Australia Pty Ltd
    Open grant
  • 2011 - 2013
    Improving anxiety assessment and management in people with dementia: Validation of an informant measure and pilot testing of a multi-component behavioural intervention
    Queensland University of Technology
    Open grant
  • 2011 - 2013
    Improving diagnostic methods of anxiety disorders in Parkinson's disease
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2011 - 2013
    Novel methods for early detection of anxiety in Parkinson's disease
    Parkinson's Queensland Inc
    Open grant
  • 2010 - 2015
    MBF Research Support Award for research into Psychiatry and Clinical Neuroscience
    Mayne Bequest Fund
    Open grant
  • 2010 - 2013
    CONCERT PLUS: An Open-Label Extension of the CONCERT Protocol (DIM18) Evaluating Dimebin (Latrepirdine) in Patients with Alzheimer's Disease
    Novotech (Australia) Pty Ltd
    Open grant
  • 2010
    Integrated brain imaging and electrophysiology for clinical neurosciences
    NHMRC Equipment Grant
    Open grant
  • 2010
    Taking the 50+ Registry into the next decade: Establishing community databases for ageing research at UQ
    UQ Major Equipment and Infrastructure
    Open grant
  • 2009 - 2011
    CONCERT: A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-Blind Twelve-Month Safety and Efficacy Study evaluating Dimebon in Patients with Mild-to-moderate Alzheimer Disease on Donepezil
    Novotech (Australia) Pty Ltd
    Open grant
  • 2009 - 2011
    A multicentre randomized clinical trial of physical activity for treatment of patients with Alzheimer's Disease - Fitness for the Ageing Brain Study II - FABS II (NHMRC Project admin by Uni Melb)
    University of Melbourne
    Open grant
  • 2009 - 2011
    Development of quality indicators for an accreditation and quality framework for dementia care in acute hospitals
    The JO and JR Wicking Trust
    Open grant
  • 2009 - 2012
    Validation of a competency assessment method for persons with dementia
    NHMRC Dementia Research Grants Program
    Open grant
  • 2008 - 2010
    Open Label Extension Study of 23mg Donepezil Sustained Release in Patients with Moderate to Severe Alzheimer¿s Disease (E2020-G000-328)
    Icon Clinical Research Pty Limited
    Open grant
  • 2008 - 2009
    A randomised single-blind placebo-controlled study to investigate the safety tolerability immunogenicity pharmacokinetics and pharmacodynamics of intravenous infusion of GSK933776 in Alheimers patient
    Glaxo Smith Kline Aust. Pty Ltd
    Open grant
  • 2008 - 2011
    Clinical outcomes, staff and carer perceptions of acute hospitalisation of patients with dementia
    NHMRC Dementia Research Grants Program
    Open grant
  • 2008 - 2009
    Study AZ3110866: A fixed dose study of SB-742457 versus placebo when added to existing Donepezil treatment in subjects with mild-to-moderate Alzheimer's disease
    Glaxo Smith Kline Aust. Pty Ltd
    Open grant
  • 2008 - 2012
    An efficacy study of a cognitive-communicative intervention to improve transition to residential care in dementia.
    NHMRC Dementia Research Grants Program
    Open grant
  • 2007 - 2010
    Enhancing transition from home to residential care in dementia
    The JO and JR Wicking Trust
    Open grant
  • 2007 - 2009
    Phase1 randomized placebo-controlled double blind dose-escalation study of safety tolerability pharmacokinetics pharmacodynamics & immunogenicity of intravenous dose PF-04360365 (RN119) - altzheimers
    Pfizer Pty Ltd
    Open grant
  • 2007 - 2011
    Synaptic dysfunction in Alzheimer's Disease
    Alzheimer's Association
    Open grant
  • 2007 - 2009
    Double-Blind, Parallel-Group Comparison of 23mg Donepezil Sustained Release to 10mg Donepezil Immediate Release in Patients with Moderate to Severe Alzheimer's Disease
    Icon Clinical Research Pty Limited
    Open grant
  • 2007 - 2010
    Prospective study of the emergence of syndromal and sub-syndromal anxiety and depression during cognitive decline.
    NHMRC Dementia Research Grants Program
    Open grant
  • 2007 - 2009
    Validation of Cognitive Assessments using Telecommunication
    NHMRC Project Grant
    Open grant
  • 2006 - 2007
    Implicit learning and cognitive communicative interventions in Alzheimer's disease
    UQ FirstLink Scheme
    Open grant
  • 2006 - 2009
    Alzheimer's Disease Research Centre
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2006
    Efficacy of agomelatine (25 to 50mg/day) given orally on quality remission in elderly depressed patients after a 12-week treatment period. A randomised, double-blind, flexible dose, international....
    Servier
    Open grant
  • 2004 - 2005
    Cogni-screen
    Telstra
    Open grant
  • 2004
    A prospective study of incident neuropsychiatric symptoms in late onset Alzheimer's diseas
    UQ External Support Enabling Grant
    Open grant
  • 2003 - 2008
    A randomized, multicenter, double-blind, placebo-controlled, 18 month study of the efficacy of xaliproden in patients with mild to moderate dementia of the Alzheimer's type. Protocol No. EFC 2724.
    SANOFI - SYNTHELABO AUSTRALIA PTY LTD
    Open grant
  • 2003 - 2005
    How well do health and community services help older people with neurodegenerative disorders and their family caregivers?
    NHMRCARC Ageing Well, Ageing Productively Program
    Open grant
  • 2002 - 2006
    Optimising Cognitive Screening In General Practice
    NHMRC Project - Development Grant
    Open grant
  • 2001 - 2002
    Genetic research into the development of schizophrenia
    Open grant
  • 2001 - 2002
    Ongoing research by the Queensland Centre for Schizophrenia Research
    Queensland Health
    Open grant
  • 2001 - 2002
    Statistical data modelling of non-genetic risk factors for schizoprehnia through epidemiologial investigation of mental health registers
    Queensland Health
    Open grant
  • 2001
    Placebo controlled evaluation of Glantamine in the treatment of Alzheimer's Disease: safety and efficacy of a controlled release formulation.
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2000 - 2001
    A multicentre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate once daily doses of AIT-082 over 24 weeks in probable Alzheimer's disease patients. Protocol #082-99-006.
    CroMedica Pty Ltd
    Open grant
  • 2000 - 2003
    Depression in Stroke Patients
    Queensland Health
    Open grant
  • 1999 - 2000
    Major depression: clinical practice guidelines
    Queensland Health
    Open grant
  • 1998 - 1999
    Clinical outcome indicators for major depression
    Queensland Health
    Open grant
  • 1997 - 1999
    Clinical protocol for double blind, randomised, placebo controlled comparative study of celecoxib (SC-58635) for the inhibition of progression of Alzheimer's Disease
    Parexel International Pty Ltd
    Open grant
  • 1995
    Prevalence and correlates of disruptive vocalisation in nursing home residents
    Utah Foundation Governor's Trust
    Open grant

Availability

Professor Gerard Byrne is:
Not available for supervision

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Gerard Byrne directly for media enquiries about:

  • Ageing and psychiatry
  • Alzheimer's disease
  • Anxiety disorders
  • Behavioural problems in the elderly
  • Bereavement - and psychiatry
  • Dementia
  • Depression
  • Elderly - psychiatry
  • Geriatric psychiatry
  • Health - mental
  • Mental health
  • Nursing homes - and psychiatry
  • Older people and psychiatry
  • Psychiatry
  • Psychosis
  • Quality of life and mental health
  • Senior citizens and psychiatry
  • Vascular dementia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au